Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinica…
Biotechnology
US, San Carlos [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Iovance Biotherapeutics, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDIovance Biotherapeutics, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Iovance Biotherapeutics, Inc..
If you want to see a demo, head over to the financial segments of AAPL